Madison and Sarah's story

"They said my girls may not survive, and I was critical..."

“They said my babies may not survive, and I was critical—immediate delivery was required to save my life. You wouldn’t wish it on your worst enemy.” 

Deborah, recalling the moment she was diagnosed with severe pre-eclampsia.

Pre-eclampsia is a serious medical condition of pregnancy characterised by rapidly increasing blood pressure and, without swift action, stroke and seizures.

There is no cure, and when severe, it threatens the lives of both the mother and her unborn child—forcing doctors to perform emergency caesareans at dangerously early stages of pregnancy.

In Deborah’s case, she was only five months into her pregnancy with twin girls when she was diagnosed. She’ll never forget how it happened:

“At 25 weeks my blood pressure had gone through the roof, my organs were shutting down and I had swelling on the brain. My doctor told me that it was time for the girls to come out.”

Deborah and her husband Kade’s main concern was whether their twins, Madison and Sarah, would survive. What they didn’t realise though, was that, even if their girls made it, there would be a high chance they’d be left with severe, life-long disabilities.

Can you imagine facing this reality? 

Miraculously, Madison and Sarah survived their delivery. And thanks to the expert medical care they received from the team at Mater, 146 days later they made it home from hospital without any lasting health problems. 

But Madison and Sarah are lucky. 

“Every single night, I go into their bedroom—even now they're nine years old—and make sure they're breathing. I think I'll always do that; just look at them and have a little think, and remember just how lucky we are to have them.”

They are the exception, not the rule. Which is why researchers still need help from generous supporters like you, to change the odds for these tiny, precious lives today.

Support

Mater Little Miracles

By supporting Mater Little Miracles you will be helping the 2000 seriously ill and premature babies cared for at Mater each year, and investing in promising research to help more babies born sick or too early to survive.